| For: | Chidambaram D, Subashini V, Nanthanalaxmi M, Saranya I, Selvamurugan N. Regulation of matrix metalloproteinase-13 in cancer: Signaling pathways and non-coding RNAs in tumor progression and therapeutic targeting. World J Clin Oncol 2025; 16(6): 105996 [PMID: 40585828 DOI: 10.5306/wjco.v16.i6.105996] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v16/i6/105996.htm |
| Number | Citing Articles |
| 1 |
Joaquim Faria Monteiro, Alexandrina Fernandes, Diogo Gavina Tato, Elias Moreira, Ricardo Ribeiro, Henrique Reguengo, Jorge Gonçalves, Paula Fresco. Optimizing Anti-PD1 Immunotherapy: An Overview of Pharmacokinetics, Biomarkers, and Therapeutic Drug Monitoring. Cancers 2025; 17(19): 3262 doi: 10.3390/cancers17193262
|
| 2 |
Evangelia Krikou, Ioanna A. Anastasiou, Panagiotis Sarantis, Hariklia Gakiopoulou, Irini Theochari, Dimitra Grigoriadou, Andreas C. Lazaris, Eleftheria Lakiotaki. Advances in Extracellular Matrix Metalloproteinases: Implications for Renal Cell Carcinoma Pathophysiology, Diagnostics, and Therapeutics. Medicines 2026; 13(1): 9 doi: 10.3390/medicines13010009
|
| 3 |
Yimao Wu, Zichang Chen, Xiaoyan Chen, Yinting Hu, Yunqi Ma. Recent advances in the investigation of the regulatory network underlying reactive nitrogen species-mediated tumorigenesis: molecular mechanisms and targeted therapeutic strategies. Redox Report 2025; 30(1) doi: 10.1080/13510002.2025.2564593
|
| 4 |
Sendegul Yildirim, Momoka Nagamine, Myoung Hwan Kim, Amanda Becceneri, Nazmiye Celik, Ilayda Namli, Todd M Umstead, Zissis C Chroneos, Gamze Tanriover, Ibrahim T Ozbolat. Therapeutic potential of TAS-115 in 3D breast cancer models. Biofabrication 2026; 18(1): 015011 doi: 10.1088/1758-5090/ae2400
|
